and the european medicines agency sticks to its line that the benefits oftheastra zenecacoby job outweigh the risks but the regulator says blood clot should now be listed as a very rare side effect of the drug.
and the european medicines agency sticks to its line that the benefits of the astra zeneca coby job outweigh the risks but the regulator says blood clot should now be listed as a very rare side effect of the drug.